Start-UpActivities
Efficient trial start-up is critical for the timely and successful execution of your clinical study. We optimize the start-up phase through careful planning, effective coordination, and agile execution, ensuring your trial initiates rapidly and in full compliance.
We support you with
Study Feasibility and Site Selection
Careful identification, evaluation, and selection of qualified investigational sites tailored to your therapeutic and operational requirements.
Operational and Project Plans
Detailed and customized planning, clearly defining timelines, responsibilities, and deliverables to accelerate trial initiation.
Essential Document Preparation
Comprehensive preparation, collection, and management of all required regulatory and site-specific documentation, facilitating Swissmedic and Ethics Committee submissions and approvals.
Clinical Trial Agreements
Negotiation and finalization of site agreements, supporting swift onboarding of study sites.
Database Set-up and Validation
Implementation of robust clinical data management systems ensuring precise, timely, and compliant data collection from study start.
At GALSER, we proactively address potential hurdles early, ensuring your clinical trial starts effectively and remains on track from day one.
Faq
Feedback from our clients
“GALSER team has shown a great mix of professionalism, flexibility/adaptability and profound knowledge of the human research landscape in Switzerland”
01
/05
“The GALSER team guided us through the Swiss regulatory process with clear advice and great responsiveness. Their support made the entire submission much easier than we anticipated.”
02
/05
“A remarkable project leader who managed to deliver a high-quality protocol in a very short time”
03
/05
“We were impressed by GALSER’s strong relationships with the study sites and their ability to keep things moving despite the usual challenges. It really helped us stay on track”
04
/05
“Your level of detail and expertise really stand out. It’s been a real pleasure working together!”
05
/05
